Literature DB >> 17636373

Cognitive executive functioning in relation to HIV medication adherence among gay, bisexual, and other men who have sex with men.

Todd M Solomon1, Perry N Halkitis.   

Abstract

A longitudinal study of 300 HIV-positive gay, bisexual or non-gay-identified men-who-have-sex-with-men was undertaken to consider patterns relating to HIV medication adherence. The purpose of our analyses was to consider the rate of adherence in relation to both age and executive functioning as assessed by the Trail Making Test A and B. Executive functioning was assessed at baseline and month 10. Our analytic sample consisted of 213 men who remained on the same protease inhibitor throughout the assessment timeframe. Adherence rates were relatively high with more than 50% of the sample maintaining a 95%+ adherence rate at both baseline and month 10. Analyses at baseline indicated executive functioning and age were related to rate of adherence. Analyses at month 10 indicated no significant relations. Findings support previous research and suggest that the status of executive functioning as well as age be given consideration when working with HIV-positive individuals.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17636373     DOI: 10.1007/s10461-007-9273-0

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  11 in total

Review 1.  The relationship between neuropsychological functioning and HAART adherence in HIV-positive adults: a systematic review.

Authors:  Travis I Lovejoy; Julie A Suhr
Journal:  J Behav Med       Date:  2009-03-17

2.  Specifying Associations Between Conscientiousness and Executive Functioning: Mental Set Shifting, Not Prepotent Response Inhibition or Working Memory Updating.

Authors:  Kimberly A Fleming; Samantha J Heintzelman; Bruce D Bartholow
Journal:  J Pers       Date:  2015-02-11

3.  Executive functioning as a mediator of the relationship between premorbid verbal intelligence and health risk behaviors in a rural-dwelling cohort: a Project FRONTIER study.

Authors:  Chloe V Menon; Danielle R Jahn; Cortney B Mauer; Sid E O'Bryant
Journal:  Arch Clin Neuropsychol       Date:  2012-11-28       Impact factor: 2.813

4.  Cannabis use and HIV antiretroviral therapy adherence and HIV-related symptoms.

Authors:  Marcel O Bonn-Miller; Megan L Oser; Meggan M Bucossi; Jodie A Trafton
Journal:  J Behav Med       Date:  2012-10-07

5.  The relationship between cognitive change and physical health and behavioural outcomes in a Ugandan cohort of adults living with HIV - a longitudinal study.

Authors:  G Spies; C A Denckla; S Mall; J Levin; S Seedat; N Nakasujja; E Kinyanda
Journal:  AIDS Care       Date:  2018-11-13

6.  Cognitive factors associated with adherence to oral antiestrogen therapy: results from the cognition in the study of tamoxifen and raloxifene (Co-STAR) study.

Authors:  Heidi D Klepin; Ann M Geiger; Hanna Bandos; Joseph P Costantino; Stephen R Rapp; Kaycee M Sink; Julia A Lawrence; Hal H Atkinson; Mark A Espeland
Journal:  Cancer Prev Res (Phila)       Date:  2013-11-19

7.  Neurocognitive impairment and medication adherence in HIV patients with and without cocaine dependence.

Authors:  Christina S Meade; Nina A Conn; Linda M Skalski; Steven A Safren
Journal:  J Behav Med       Date:  2010-09-21

8.  Executive function fails to predict smoking outcomes in a clinical trial to motivate smokers to quit.

Authors:  Andrew T Fox; Laura E Martin; Jared Bruce; Jose L Moreno; Vincent S Staggs; Hyoung S Lee; Kathy Goggin; Kari Jo Harris; Kimber Richter; Christi Patten; Delwyn Catley
Journal:  Drug Alcohol Depend       Date:  2017-04-13       Impact factor: 4.492

9.  Relationships among neurocognitive status, medication adherence measured by pharmacy refill records, and virologic suppression in HIV-infected persons.

Authors:  Adriana S A Andrade; Reena Deutsch; Shivaun A Celano; Nichole A Duarte; Thomas D Marcotte; Anya Umlauf; J Hampton Atkinson; J Allen McCutchan; Donald Franklin; Terry J Alexander; Justin C McArthur; Christina Marra; Igor Grant; Ann C Collier
Journal:  J Acquir Immune Defic Syndr       Date:  2013-03-01       Impact factor: 3.731

10.  Future directions of the National Institutes of Health Science of Behavior Change Program.

Authors:  Chandra Keller; Rebecca A Ferrer; Rosalind B King; Elaine Collier
Journal:  Transl Behav Med       Date:  2021-04-10       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.